Citation Impact
Citing Papers
Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus
2017
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
2021 Standout
The Aryl Hydrocarbon Receptor–Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple Sclerosis
2021
Myelin damage and repair in pathologic CNS: challenges and prospects
2015
Parkinson disease
2017 Standout
Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
2019
An organotypic slice culture model of chronic white matter injury with maturation arrest of oligodendrocyte progenitors
2011
Kallikrein 6 Regulates Early CNS Demyelination in a Viral Model of Multiple Sclerosis
2012
Activation of the STING-Dependent Type I Interferon Response Reduces Microglial Reactivity and Neuroinflammation
2017
Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond
2011
Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms
2019 Standout
Chemical kinetics for drug discovery to combat protein aggregation diseases
2014
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species
2013 Standout
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
2013
Widespread microglial activation in patients deceased from traumatic brain injury
2015
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
M1 and M2 immune activation in Parkinson’s Disease: Foe and ally?
2014
Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease
2018
Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain
2010
Tau in physiology and pathology
2015 Standout
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Biological roles of glycans
2016 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Inhibition of Amyloid Formation
2012
Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
2012
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
2020 Standout
Astrocytes from the Contused Spinal Cord Inhibit Oligodendrocyte Differentiation of Adult Oligodendrocyte Precursor Cells by Increasing the Expression of Bone Morphogenetic Proteins
2011
The Glymphatic System: A Beginner’s Guide
2015 Standout
TREM2 regulates microglial cell activation in response to demyelination in vivo
2015
Small talk: microbial metabolites involved in the signaling from microbiota to brain
2019
Defining Disease Activity and Response to Therapy in MS
2017
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Comparing the Autoantibody Levels and Clinical Efficacy of Double Filtration Plasmapheresis, Immunoadsorption, and Intravenous Immunoglobulin for the Treatment of Late‐onset Myasthenia Gravis
2009
Design of amyloidogenic peptide traps
2024 StandoutNobel
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
2013 Standout
Butyrate suppresses demyelination and enhances remyelination
2019
A Reappraisal of Humoral Immunity Based on Mechanisms of Antibody‐Mediated Protection Against Intracellular Pathogens
2006
Myeloid cells — targets of medication in multiple sclerosis
2016
Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology
2015 StandoutNobel
Innate Immunity in the CNS: Redefining the Relationship between the CNS and Its Environment
2013
The Pathobiology of Vascular Dementia
2013 Standout
Immunity to fungal infections
2011 Standout
Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV
2010
A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
2012
The amyloid state and its association with protein misfolding diseases
2014 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Altered Nrf2 Signaling Mediates Hypoglycemia-Induced Blood–Brain Barrier Endothelial Dysfunction In Vitro
2015
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
2011
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
Neuroinflammation: the devil is in the details
2016 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Multiple Sclerosis
2018 Standout
Clinical trials and late‐stage drug development for A lzheimer's disease: an appraisal from 1984 to 2014
2014
Astrocytes in multiple sclerosis
2016
Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro
2013 StandoutNobel
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
2012 Standout
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
Macrophages and CNS remyelination
2014
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Myelination of the Nervous System: Mechanisms and Functions
2014
Regulated genes in psoriatic skin during treatment with fumaric acid esters
2014
Microglial M1/M2 polarization and metabolic states
2015 Standout
Disease-modifying treatments for Alzheimer’s disease
2011
TREM2 sustains microglial expansion during aging and response to demyelination
2015
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Works of Refik Pul being referenced
Cerebellar Cortical Demyelination in the Murine Cuprizone Model
2009
Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients
2016
Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity
2010
Basic principles of intravenous immunoglobulin (IVIg) treatment
2006
Pivotal role of choline metabolites in remyelination
2014
Comparison of Intravenous Immunoglobulin Preparations on Microglial Function In Vitro: More Potent Immunomodulatory Capacity of an IgM/IgA-Enriched Preparation
2002
Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination
2012
Intravenous Immunoglobulins as a Treatment for Alzheimerʼs Disease
2010
Antibody-based therapy in Alzheimer's disease
2011
Effects of fumaric acid esters on blood–brain barrier tight junction proteins
2013
CCL5 induces a pro-inflammatory profile in microglia in vitro
2011
Glatiramer Acetate Increases Phagocytic Activity of Human Monocytes In Vitro and in Multiple Sclerosis Patients
2012
Matrix Metalloproteinases and Their Tissue Inhibitors in Cuprizone-Induced Demyelination and Remyelination of Brain White and Gray Matter
2011
Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing–remitting multiple sclerosis
2015
The antiviral drug ganciclovir does not inhibit microglial proliferation and activation
2015
McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity
2016
Characterisation of microglia during de- and remyelination: Can they create a repair promoting environment?
2011